Dr. Caram conducts research investigating minimizing the harm done to patients with cancer-directed therapies and understanding the factors that variation in care of castration-resistant prostate cancer, including non-evidence-based use of therapies, and investigating the clinical and non-clinical factors that guide treatment decisions, including patients' access to care and provider effects on various treatment decisions.
